Filter posts

Morning Consult: Medicare’s Flawed Part B Drug Experiment Could Harm Patients

In today’s Morning Consult, the Community Oncology Alliance’s Rose Gerber has an excellent piece detailing …

Judd Gregg: Biodefense Funding Is Crucial to National Security

Writing in the Morning Consult, former Senator Judd Gregg explains critical role of federal programs …

JAMA Study Finds Vast Majority of Requests for Clinical Trial Data Granted

In 2014, BIO members reaffirmed and broadened their commitment to responsibly share data from clinical …

ICYMI: John Lechleiter: An Empty Obama-Clinton-Sanders Plan on Drug Costs

Writing in the Wall Street Journal today, Eli Lilly and Company Chairman, President and CEO …

The Guardian: Global defence system to fight virus threats urgently needed

Fresh on the heels of the recent Ebola epidemic, the current Zika virus threat has …

Reality Check for AARP

This morning, AARP released yet another misleading report on prescription drug prices that ignores key …

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

The 18th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging …

#BIOCEO16 Session Recap: Regulatory Policy Outlook—PDUFA VI and You

The second day of #BIOCEO16 kicked off this morning with a look ahead to PDUFA …

#BIOCEO16 Fireside Chat with Senator Chuck Schumer

New York Senator Chuck Schumer joined attendees at the 2016 BIO CEO & Investor Conference …

Tomorrow: From Volume to Value: Designing a Patient-Centered Healthcare System (Webcast)

Tomorrow at the Newseum, The Hill will be hosting a live discussion about the transition …